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Clariﬁcations on Conﬂicting Results Published on the
Ampliﬁcation of the Mala s 1 Allergen Gene Sequences
To the Editor:
In the December issues of the Journal of Investigative Derma-
tology (JID) (Gaitanis et al, 2003—Online publication 26-11-
2003, PMID 14675212) and Medical Mycology (Andersson et al,
2003—Online publication 12-03, PMID 14675212), two inde-
pendent publications investigated the distribution of genes
coding for Malassezia allergens. Although the methodology and
scope of the two studies did not differ significantly, contradic-
tory results were reported regarding the PCR amplification of
sequences coding for the Mala s 1 allergen.1
In the letter published in the JID, the authors (Gaitanis et al,
2003) amplified Mala s 1 allergen coding sequences only from
the clinical isotype strain ATCC 42132 and from 13 reference
and clinical M. sympodialis but not from 22 Type or clinical
strains of any other Malassezia species. This result was ob-
tained only after optimizing the PCR conditions.
In the Medical Mycology article, PCR products correspond-
ing to the size of the complete coding sequence of the same
gene were amplified from genomic DNA of Type strains M.
globosa CBS 7966, M. obtusa CBS 7876, and M. pachyderm-
atis CBS 1879 (Andersson et al, 2003). No mRNA was detected
from any of these Malassezia species by RT-PCR, denoting
absence of the expression of the allergen.
In order to ensure uniformity of the PCR outcome regarding
amplification of Mala s 1 sequences from Malassezia species,
our two groups collaborated exchanging raw data and unpub-
lished observations. It was subsequently ascertained that the
PCR primers used in both studies overlap different regions of
the Mala s 1 complementary DNA sequence (Gene Bank Ac-
cession No. X96486; Schmidt et al, 1997). In the Medical My-
cology study, the forward and reverse primers overlap the (22–
44) and (1085–1058) regions, respectively, whereas in the JID
study the corresponding primers overlap (120–140) and (860–
841) regions, respectively. Therefore, it cannot be excluded that
the disagreements between the published data might be be-
cause of differences in the nucleotide sequences in these dif-
ferent Mala s 1 regions among the various Malassezia species,
which can in turn influence annealing of the respective primer
pairs to the different DNA templates. Unfortunately, the primers
designed from the Mala s 1 cDNA coding sequence (Gaitanis
et al, 2003) could not be simultaneously aligned to the Anders-
son et al (2003) partial sequences from the PCR products.
Sporadic and inconsistent PCR products were amplified in
earlier experiments from M. globosa, M. obtusa, and M. pach-
ydermatis.2 This phenomenon was resolved through PCR op-
timization and titration with 2-pyrolidone (Gaitanis et al, 2003).
Additionally, no Mala s 1 gene sequences were amplified
from nine additional Type and reference M. pachydermatis
strains that were retrospectively tested (M. pachydermatis
CBS1880, CBS1881, CBS 1882, CBS 1883, CBS 1884, CBS
1885, CBS 6540, CBS 7044, CBS 7925). Andersson et al (2003)
reported absence of Mala s 1 allergen transcripts from M.
globosa, M. obtusa, and M. pachydermatis, which regarding
M. globosa, has also been supported by earlier observations
(Koyama et al, 2001).
In conclusion, sequences corresponding to the complete
coding sequence of the Mala s 1 gene are amplified, from
both DNA and cDNA, solely from M. sympodialis strains
(Andersson et al, 2003) when increased stringency and op-
timum PCR conditions are attained (Gaitanis et al, 2003). In
one of the studies (Andersson et al, 2003), the Mala s 1 se-
quence could also be PCR amplified from the DNA of
M. globosa, M. obtusa, and M. pachydermatis. These PCR
products, however, were only partially sequenced and wheth-
er their full-nucleotide sequence also shows 100% sequence
similarities to Mala s 1 has to be determined.
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